FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Seeks Advisory Panel Input on Galleri Cancer Screening Test

FDA seeks advisory committee input on the benefits and risks of GRAIL's Galleri multi-cancer early detection test after two pivotal studies showed tha...

Human Drugs

Drug Groups Seek Changes to FDA's Distributed Manufacturing Rule

Three major pharmaceutical industry associations urge FDA to revise its proposed distributed manufacturing rule to provide greater flexibility for exi...

FDA General

Reg Update on Non-Animal Testing Methods in Drug Development

FDA has issued a direct final rule updating its regulations to clarify that non-animal testing methods may be used, where appropriate, to establish th...

latest-news-card-1
Medical Devices

Stronger FDA Oversight of Third-Party Device Reviewers Needed: GAO

A new Government Accountability Office finds gaps in FDA's oversight of third-party organizations that review 510(k) medical device submissions, inclu...

latest-news-card-1
Medical Devices

FDA Identifies CooperSurgical Infant Nasal CPAP Recall as Class 1

FDA classifies as Class 1 a CooperSurgical recall of certain INCA Infant Nasal CPAP Complete Sets and Neonatal Nasal CPAP Replacement Sets due to a lo...

latest-news-card-1
Human Drugs

Insmed sNDA Gets Priority Review for Arikayce Full Approval

FDA accepts for priority review an Insmed supplemental NDA seeking traditional approval for Arikayce (amikacin liposome inhalation suspension) for tre...

latest-news-card-1
Marketing

Ardelyx Uses DTC Crackdown Lessons to Shape Ibsrela TV Ad

Ardelyx says it incorporated lessons from FDA's recent prescription drug advertising enforcement actions into its first television advertising campaig...

latest-news-card-1
FDA General

FDA EDDO Control Strategy Guidance Analyzed

Staff from FDA and several drug companies use a Journal of Regulatory Affairs article to explain a 2024 FDA guidance on optimizing EDDO control strate...

latest-news-card-1
Human Drugs

FDAs OCP Maps Out AI, Modeling and Evidence Priorities

A new report by CDERs Office of Clinical Pharmacology says regulatory science will have to evolve alongside increasingly complex therapies, with great...

latest-news-card-1
Human Drugs

User Fee Agreement Opens New Tools to Head Off CRLs: Analysis

FDAs proposed drug user fee commitments could give drug and biologics sponsors several new opportunities to address manufacturing facility problems be...